Predicting Survival for Surgery of Metastatic Spinal Cord Compression in Prostate Cancer
Authors:
- Sead CrnalicSCSead Crnalic
- Richard LöfvenbergRLRichard Löfvenberg
- Christer HildingssonCHChrister Hildingsson
- 15 December 2012
- journal article
- abstracts
- Published by Wolters Kluwer Health in Spine
- Vol. 37 (26) , 2168-2176
Abstract
Study Design. We retrospectively analyzed prognostic factors for survival in patients with prostate cancer operated for metastatic spinal cord compression. Objective. The aim was to obtain a clinical score for prediction of survival after surgery. Summary of Background Data. Survival prognosis is important when deciding about treatment of patients with metastatic spinal cord compression. The criteria for identifying patients with prostate cancer who may benefit from surgical treatment are unclear. Methods. The study comprised 68 consecutive patients with prostate cancer operated for metastatic spinal cord compression at Umeå University Hospital, Sweden. The indication for surgery was neurological deficit; 53 patients had hormone-refractory prostate cancer and 15 patients had previously untreated, hormone-naïve prostate cancer. In 42 patients, posterior decompression was performed and 26 patients were operated with posterior decompression and stabilization. Results. A new score for prediction of survival was developed on the basis of the results of survival analyses. The score includes hormone status of prostate cancer, Karnofsky performance status, evidence of visceral metastasis, and preoperative serum prostate-specific antigen (PSA). The total scores ranged from 0 to 6. Three prognostic groups were formulated: group A (n = 32) with scores 0–1; group B (n = 23) with scores 2–4, and group C (n = 12) with scores 5–6. The median overall survival was 3 (0.3–20) months in group A, 16 (1.8–59) months in group B, and more than half (7 of 12) of patients were still alive in group C. Conclusion. We present a new prognostic score for predicting survival of patients with prostate cancer after surgery for metastatic spinal cord compression. The score is easy to apply in clinical practice and may be used as additional support when making decision about treatment.Keywords
This publication has 26 references indexed in Scilit:
- Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancerActa Orthopaedica, 2011
- Nuclear androgen receptor staining in bone metastases is related to a poor outcome in prostate cancer patientsEndocrine-Related Cancer, 2010
- Surgical management of prostate cancer metastatic to the spineJournal of Neurosurgery: Spine, 2009
- A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor PrognosisSpine, 2005
- Surgical Strategy for Spinal MetastasesSpine, 2001
- Spinal metastases from solid tumors. Analysis of factors affecting survivalCancer, 1995
- Survival after surgery for spinal and extremity metastases: Prognostication in 241 patientsActa Orthopaedica, 1995
- Scoring System for the Preoperative Evaluation of Metastatic Spine Tumor PrognosisSpine, 1990
- The Role of Surgical Management for Symptomatic Spinal Cord Compression in Patients with Metastatic Prostate CancerJournal of Urology, 1989
- The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegiaSpinal Cord, 1969